BBIO Bridgebio Pharma Inc
Bridgebio Pharma Inc price
0% Past Week
Market Cap
5.02B
Day’s Range
52W Range
Volume (3M)
1.44M
Price-Earnings Ratio
-7.38
Revenue
9.43M
Bridgebio Pharma Inc Latest News



Upcoming Events
22
FEB
REPORTS
Bridgebio Pharma Inc Q4 2023 earnings report is expected to be released before the market opens
Consensus
Moderate Buy
Price Target
50.00
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
37
Very Low
Industry
Avg. 44
39
Environment
44
Social
24
Governance
People Also Bought
- MRTX Mirati Therapeutics Inc 0.21%
- AXSM Axsome Therapeutics Inc 1.64%
- IMGN ImmunoGen Inc 0.50%
- ITCI Intra-Cellular Therapies Inc 0.61%
AUPH Aurinia Pharmaceuticals Inc. -1.04%